AllianceBernstein’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $765K | Hold |
68,100
| – | – | ﹤0.01% | 2429 |
|
|
2025
Q1 | $311K | Sell |
68,100
-5,900
| -8% | -$27K | ﹤0.01% | 2755 |
|
|
2024
Q4 | $417K | Sell |
74,000
-9,450
| -11% | -$53.3K | ﹤0.01% | 2718 |
|
|
2024
Q3 | $404K | Hold |
83,450
| – | – | ﹤0.01% | 2771 |
|
|
2024
Q2 | $407K | Buy |
83,450
+19,040
| +30% | +$92.9K | ﹤0.01% | 2776 |
|
|
2024
Q1 | $855K | Buy |
64,410
+21,910
| +52% | +$291K | ﹤0.01% | 2347 |
|
|
2023
Q4 | $592K | Hold |
42,500
| – | – | ﹤0.01% | 2527 |
|
|
2023
Q3 | $564K | Sell |
42,500
-33,170
| -44% | -$440K | ﹤0.01% | 2505 |
|
|
2023
Q2 | $1.42M | Sell |
75,670
-3,100
| -4% | -$58.1K | ﹤0.01% | 2092 |
|
|
2023
Q1 | $1.14M | Sell |
78,770
-100
| -0.1% | -$1.44K | ﹤0.01% | 2162 |
|
|
2022
Q4 | $1.53M | Buy |
78,870
+5,100
| +7% | +$98.7K | ﹤0.01% | 2068 |
|
|
2022
Q3 | $2.53M | Buy |
73,770
+33,570
| +84% | +$1.15M | ﹤0.01% | 1728 |
|
|
2022
Q2 | $614K | Buy |
40,200
+6,100
| +18% | +$93.2K | ﹤0.01% | 2587 |
|
|
2022
Q1 | $778K | Buy |
34,100
+20,300
| +147% | +$463K | ﹤0.01% | 2502 |
|
|
2021
Q4 | $509K | Sell |
13,800
-2,200
| -14% | -$81.1K | ﹤0.01% | 2724 |
|
|
2021
Q3 | $752K | Buy |
16,000
+9,781
| +157% | +$460K | ﹤0.01% | 2597 |
|
|
2021
Q2 | $375K | Buy |
+6,219
| New | +$375K | ﹤0.01% | 2921 |
|